{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T12:52:47Z","timestamp":1702817567520},"reference-count":33,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.beha.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T01:45:44Z","timestamp":1374371144000},"page":"183-190","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["NOACs for thromboprophylaxis in medical patients"],"prefix":"10.1016","volume":"26","author":[{"given":"Alexander (Ander) T.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.beha.2013.07.002_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beha.2013.07.002_bib2","doi-asserted-by":"crossref","first-page":"b4583","DOI":"10.1136\/bmj.b4583","article-title":"Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study","volume":"339","author":"Sweetland","year":"2009","journal-title":"The British Medical Journal"},{"issue":"9610","key":"10.1016\/j.beha.2013.07.002_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"371","author":"Cohen","year":"2008","journal-title":"Lancet"},{"issue":"3 Suppl.","key":"10.1016\/j.beha.2013.07.002_bib4","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy","volume":"126","author":"Geerts","year":"2004","journal-title":"Chest"},{"issue":"6 Suppl.","key":"10.1016\/j.beha.2013.07.002_bib5","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition.)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.beha.2013.07.002_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/bjs.1800780725","article-title":"Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988","volume":"78","author":"Lindblad","year":"1991","journal-title":"The British Journal of Surgery"},{"issue":"2","key":"10.1016\/j.beha.2013.07.002_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1076029607308389","article-title":"Pulmonary embolism in medical patients: an autopsy-based study","volume":"14","author":"Kakkar","year":"2008","journal-title":"Clinical and Applied Thrombosis\/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis\/Hemostasis"},{"issue":"3","key":"10.1016\/j.beha.2013.07.002_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1538-7836.2007.02847.x","article-title":"Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis","volume":"6","author":"Lloyd","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1016\/j.beha.2013.07.002_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"2 Suppl","key":"10.1016\/j.beha.2013.07.002_bib10","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.beha.2013.07.002_bib11","first-page":"65","article-title":"The changing pattern of venous thromboembolic disease","volume":"26","author":"Cohen","year":"1996","journal-title":"Haemostasis"},{"issue":"12","key":"10.1016\/j.beha.2013.07.002_bib12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/jcp.2003.013581","article-title":"Fatal pulmonary embolism in hospitalised patients: a necropsy review","volume":"57","author":"Alikhan","year":"2004","journal-title":"Journal of Clinical Pathology"},{"issue":"18","key":"10.1016\/j.beha.2013.07.002_bib13","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","article-title":"Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery","volume":"318","author":"Collins","year":"1988","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.beha.2013.07.002_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/0003-4819-155-9-201111010-00008","article-title":"Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline","volume":"155","author":"Lederle","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.beha.2013.07.002_bib15","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1055\/s-0037-1615775","article-title":"Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty\u2013a meta-analysis","volume":"85","author":"Cohen","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.beha.2013.07.002_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1302\/0301-620X.94B2.27850","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials","volume":"94","author":"Raskob","year":"2012","journal-title":"The Journal of Bone and Joint Surgery British Volume"},{"issue":"3","key":"10.1016\/j.beha.2013.07.002_bib17","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1160\/TH10-09-0601","article-title":"Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies","volume":"105","author":"Turpie","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1016\/j.beha.2013.07.002_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/11587290-000000000-00000","article-title":"A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery","volume":"34","author":"Schulman","year":"2011","journal-title":"Drug Safety: An International Journal of Medical Toxicology and Drug Experience"},{"issue":"2 Suppl.","key":"10.1016\/j.beha.2013.07.002_bib19","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.beha.2013.07.002_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11239-011-0549-x","article-title":"Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol","volume":"31","author":"Cohen","year":"2011","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"1","key":"10.1016\/j.beha.2013.07.002_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-153-1-201007060-00004","article-title":"Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial","volume":"153","author":"Hull","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"23","key":"10.1016\/j.beha.2013.07.002_bib22","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1110899","article-title":"Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients","volume":"365","author":"Goldhaber","year":"2011","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.beha.2013.07.002_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1111096","article-title":"Rivaroxaban for thromboprophylaxis in acutely ill medical patients","volume":"368","author":"Cohen","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.beha.2013.07.002_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00001721-200306000-00004","article-title":"Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study","volume":"14","author":"Alikhan","year":"2003","journal-title":"Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis"},{"issue":"10","key":"10.1016\/j.beha.2013.07.002_bib25","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/j.1538-7836.2012.04874.x","article-title":"Extended thromboprophylaxis for medically ill patients with decreased mobility: does it improve outcomes?","volume":"10","author":"Sharma","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"10.1016\/j.beha.2013.07.002_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1016\/j.beha.2013.07.002_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.beha.2013.07.002_bib28","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.25011\/cim.v34i1.15106","article-title":"Measurement of D-dimer as aid in risk evaluation of VTE in elderly patients hospitalized for acute illness: a prospective, multicenter study in China","volume":"34","author":"Fan","year":"2011","journal-title":"Clinical and Investigative Medicine, Medecine clinique et experimentale"},{"issue":"5","key":"10.1016\/j.beha.2013.07.002_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5858\/2004-128-519-COPCPW","article-title":"Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study","volume":"128","author":"Desjardins","year":"2004","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/j.beha.2013.07.002_bib30","series-title":"Presented at the annual scientific session of the American Society of Haematology; December 12, 2011","article-title":"The MAGELLAN study: an analysis of outcomes utilizing D-dimer","author":"Cohen","year":"2011"},{"issue":"9","key":"10.1016\/j.beha.2013.07.002_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beha.2013.07.002_bib32","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/j.1538-7836.2012.04908.x","article-title":"for the FONDAIR study group. Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study","volume":"10","author":"Ageno","year":"2012","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.beha.2013.07.002_bib33","author":"Clinicaltrials.gov"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T21:20:49Z","timestamp":1646169649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692613000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1521692613000236"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.07.002","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOACs for thromboprophylaxis in medical patients","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}